《临床精神病药物手册》第25版

Quick and comprehensive information on psychotropic drugs for adults.

– Accurate and up-to-date – Comparison charts help decision-making – Icons and full color – Available in print and online – Downloadable patient info sheets The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists,physicians, pharmacists, nurses, and other mental health professionals.

• Independent, unbiased, up-to-date • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options • Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug • Potential interactions and side effects summarized in comparison charts • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek • Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition

• Antidepressants chapter includes a new section on the NMDA receptor antagonist/CYP2D6 inhibitor combination product (dextromethorphan/bupropion; Auvelity extended-release tablets) • Antipsychotics updates include revised Clozapine monitoring tables which now also contain monitoring requirements for patients with or without non-benign ethnic neutropenia • Mood Stabilisers sections on Lithium and Anticonvulsants extensively revised • Dementia chapter includes a new section on Lecanemab (Leqembi), a fast-track FDA approved treatment for Alzheimer’s disease • Treatment of Substance Use Disorders includes revisions to Buprenorphine dosing section to include a rapid micro-induction method (Bernese method) that allows treatment to start without waiting for patient to be in withdrawal • Unapproved treatments of Psychiatric Disorders, Natural Health Products, and Pharmacogenetic chapters all substantially revised • New formulations and trade names include: Invega Hafyera (paliperidone long-acting 6-monthly IM injection), Subutex (buprenorphine sublingual tablets), Quviviq (daridorexant tablets)

快速而详尽的大剂量药物信息对于成年人。

- 准确且最新信息 - 对比图表帮助决策 - 图标和全彩页面 - 可以打印和在线获取 - 患者信息单下载可获得

临床精神治疗药物手册已成为精神科医生、心理学家、内科医师、药师、护士及其他心理健康专业人士的标准参考和工作工具。

- 独立的、无偏见且最新的信息 - 含有独特易读的对比图表和表格（剂量、副作用、药代动力学、相互作用…）为治疗方案快速概览 - 各类药物全面简洁的信息：处方和非处方适应症、副作用、相互作用、药理动态、年轻患者、老年人及怀孕中的注意事项，护理影响等 - 在对比图表中总结可能的相互作用和副作用 - 全部页面都采用易于识别的图标和全彩呈现方式，使你可以迅速找到你需要的所有信息 - 可下载清晰写成的患者信息单，并以打印PDF格式供使用

此书对需要最新、易用且全面总结所有相关精神药物信息的人都是必不可少的。

新版本更新内容：

- 抗抑郁药章节增加了一篇关于NMDA受体拮抗剂/ CYP2D6抑制剂组合产品（右美沙芬/苯环佐品； Auvelity缓释片）的新内容 - 抑郁症药物更新包括修订的氯米帕明监测表，现在还包含无良性种族性白细胞减少症的患者和有无良性种族性白细胞减少症患者的监测要求 - 稳定情绪剂部分对锂盐和抗惊厥药做了广泛修订 - 老年痴呆章节增加了一篇关于莱卡那米布（列齐维克）的新内容，这是一种FDA快速通过的阿尔茨海默病治疗药物 - 治疗物质使用障碍的内容包括了修订过的布托啡诺剂量部分以包含一种快速微诱导方法（伯恩兹方法），这种方法使治疗可以在患者还未戒掉之前就开始 - 精神疾病未获批疗法、天然保健品和药理学章节都做了较大范围的修订 - 新的制剂与品牌名称包括：Hafyera（帕利哌啶长效注射剂，每6个月一次）；Subutex（布托啡诺舌下片剂）；Quviviq（达德罗克辛特片剂）

本站不对文件进行储存，仅提供文件链接，请自行下载，本站不对文件内容负责，请自行判断文件是否安全，如发现文件有侵权行为，请联系管理员删除。